Changes in Siegfried Management
The Board of Directors of Siegfried Holding AG appointed Dr. René Imwinkelried, Ph.D., the company’s new Head Research & Development and member of the Executive Committee. He is currently Head of Technical Development Small Molecules at Roche in Basel. René Imwinkelried will start in his new function on September 1st, 2012.
Following a Ph.D. degree in organic chemistry from the Swiss Federal Institute of Technology (ETH) Zurich, René Imwinkelried completed a postdoctoral fellowship at both Colorado State University and Harvard University. Prior to his current position at Roche, he executed various R&D functions at Lonza between 1991 and 2004 and held the position of Head of Global Chemical and Physical Sciences at the US pharmaceutical company Schering-Plough from 2004 to 2010.
He succeeds Wolfgang Wienand, Ph.D., who held this position since August 2010 and will now focus on further developing Strategy and Mergers & Acquisitions in the Executive Committee and on his responsibility for Legal and IP Management. Wolfgang Wienand will continue to execute both functions until René Imwinkelried joins Siegfried.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Shiny_Cowbird
Current_Issues_in_Molecular_Biology

Researchers developing brain-mapping technology

For shorter approval times: New process simulates decomposition of too long stored drugs in 15 minutes - New approach represents a paradigm shift in the application of mechanochemical processes in organic chemistry
Collaboration between Pfizer and Evotec - Licence and collaboration agreement in tissue fibrosis
Platypus
Ecological_economics
Brain cells divide the work to recognize bodies
Copper(I)_iodide
